IDO1/TDO-IN-11
IDO1/TDO-IN-11 (Compound Y-13) is a dual IDO1 and TDO inhibitor, with an IC50 of 2.87 μM against hIDO1 and an IC50 of 0.08 μM against hTDO. IDO1/TDO-IN-11 inhibits NO production and ROS production. IDO1/TDO-IN-11 alleviates cellular neuroinflammatory damage and ameliorates Parkinson's disease. IDO1/TDO-IN-11 is applicable to research related to Parkinson's disease.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Formule: C18H15NO4
- Masse moléculaire:309.32
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
Description
IC50 & Target
[1]|
hIDO1 2.87 μM (IC50) |
In Vitro
IDO1/TDO-IN-11 potently inhibits purified hIDO1 (IC50 = 2.87 ± 0.93 μM) and hTDO (IC50 = 0.08 ± 0.01 μM) in cell-free biochemical assays[1].
IDO1/TDO-IN-1 potently inhibits intracellular IDO1 activity in IFN-γ-induced HeLa cells, with an IC50 of 10.97 ± 1.56 μM[1].
IDO1/TDO-IN-11 potently inhibits intracellular TDO activity in hTDO-transfected HEK-293 T cells, with an IC50 of 10.34 ± 0.55 μM[1].
IDO1/TDO-IN-11 (5-80 μM) inhibits LPS-induced NO and ROS production in a concentration-dependent manner, thereby protecting BV2 microglia from neuroinflammatory injury[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:PD mouse model[1]
-
Dosage:25, 50 mg/kg
-
Administration:i.p.; once daily; 14 days
-
Result:Significantly prevented the
MPTP-induced deficits.
Had no obvious toxicity.
Reversed PD symptoms at the pathological level (H&E staining of mice brain section).
Improved cognitive function, learning ability, and motor
performance.
Chemical Information
-
Masse moléculaire 309.32
-
Formule C18H15NO4
-
SMILES
OC1=C2C(C=C(C3=CC=C(C(OC)=O)C=C3)N=C2)=CC=C1OC
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocole
-
ROS/oxidative-stress fluorescent staining
ROS/oxidative-stress fluorescent staining uses cell-permeant fluorogenic probes that become fluorescent after oxidation inside cells or tissues; commonly used examples include DCFH-DA/DCFDA for broad cellular oxidant detection, DHE for superoxide-related signal detection, MitoSOX for mitochondrial superoxide-related signal detection, and CellROX probes for oxidative-stress-associated fluorescence readouts. The assay detects probe oxidation rather than a single ROS species unless the probe and analysis method have been chemically validated for that species. DCFH-DA enters cells, is deacetylated by intracellular esterases to DCFH, and produces fluorescent DCF after oxidation, so the readout is used as an operational measure of total cellular oxidative stress rather than a species-specific ROS measurement. DHE and MitoSOX can report superoxide-related oxidation, but red fluorescence alone can include non-specific ethidium-like oxidation products; HPLC or optimized spectral approaches are
-
Human pluripotent stem cell midbrain dopaminergic neuron differentiation
Human pluripotent stem cells are directed toward midbrain dopaminergic neurons by first inducing a neural floor-plate-like progenitor state, then patterning cells with ventralizing SHH signaling and midbrain/WNT-FGF cues, and finally maturing progenitors into neurons expressing dopaminergic markers such as TH, NURR1/NR4A2, PITX3, DAT/SLC6A3, VMAT2/SLC18A2, GIRK2/KCNJ6, FOXA2, LMX1A, and EN1. The main readouts are loss of pluripotency, acquisition of FOXA2+/LMX1A+ midbrain floor-plate progenitors, emergence of βIII-tubulin+/MAP2+ neurons, and production of TH+ dopaminergic neurons with molecular, dopamine-release, and electrophysiological features of midbrain dopaminergic identity.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)